Published in Pathobiology on November 29, 2010
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol (2012) 1.56
Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol (2011) 1.12
IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol (2014) 0.98
Graves' Disease Patients with Persistent Hyperthyroidism and Diffuse Lymphoplasmacytic Infiltration in the Thyroid Show No Histopathological Compatibility with IgG4-Related Disease. PLoS One (2015) 0.85
A small subgroup of Hashimoto's thyroiditis is associated with IgG4-related disease. Virchows Arch (2015) 0.75
Clinical Features of Patients with Basedow's Disease and High Serum IgG4 Levels. Intern Med (2017) 0.75
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope (2011) 2.55
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res (2007) 2.25
Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine (2006) 2.11
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis. Intern Med (2006) 1.90
Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J (2011) 1.72
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet (2010) 1.66
Risk factors for adjacent segment degeneration after PLIF. Spine (Phila Pa 1976) (2004) 1.65
Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg (2005) 1.63
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg (2007) 1.58
MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma. Leuk Lymphoma (2013) 1.55
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 2: Advantages of anterior decompression and fusion over laminoplasty. Spine (Phila Pa 1976) (2007) 1.54
Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood (2008) 1.53
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood (2002) 1.52
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J (2006) 1.49
Ovarian endometriosis showing decidual change and Arias-Stella reaction with biotin-containing intranuclear inclusions. Acta Cytol (2003) 1.49
Thyrotoxicosis caused by weight-reducing herbal medicines. Arch Intern Med (2005) 1.49
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab (2007) 1.49
Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid (2009) 1.48
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Clin Endocrinol (Oxf) (2009) 1.47
Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg (2012) 1.47
Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis. Endocr J (2004) 1.46
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of laminoplasty. Spine (Phila Pa 1976) (2007) 1.46
Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. World J Surg (2006) 1.46
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg (2012) 1.43
Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease. Endocr J (2004) 1.41
Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol (2004) 1.40
External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement. Laryngoscope (2013) 1.40
Ernest L. Mazzaferri, MD, MACP (1936-2013). Thyroid (2013) 1.39
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg (2006) 1.39
CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett (2006) 1.38
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab (2007) 1.35
Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab (2010) 1.34
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32
Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J Surg (2005) 1.30
Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am (2006) 1.29
Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology (2003) 1.28
CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood (2007) 1.28
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood (2003) 1.26
Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg (2005) 1.25
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Chylothorax associated with massive osteolysis (Gorham's syndrome). Ann Thorac Surg (2002) 1.23
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica (2009) 1.22
Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J Surg (2010) 1.22
The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet (2011) 1.20
Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J (2009) 1.19
Tumor thrombus of thyroid malignancies in veins: importance of detection by ultrasonography. Thyroid (2011) 1.18
Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol (2007) 1.18
Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med (2008) 1.18
Gastric inverted hyperplastic polyp. Report of four cases and relation to gastritis cystica profunda. APMIS (2002) 1.17
Autonomic dysreflexia associated with Charcot spine following spinal cord injury: a case report and literature review. Eur Spine J (2010) 1.17
Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab (2013) 1.16
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol (2002) 1.15
Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid (2010) 1.15
Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery (2008) 1.15
Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol (2009) 1.14
Menstrual disturbances in various thyroid diseases. Endocr J (2010) 1.14
Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. Thyroid (2008) 1.13
Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab (2006) 1.12
Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Mod Pathol (2012) 1.11
Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature. Virchows Arch (2002) 1.10
Colonic pseudolipomatosis, microscopically classified into two groups. J Gastroenterol Hepatol (2006) 1.07
Acute suppurative thyroiditis after fine-needle aspiration causing thyrotoxicosis. Thyroid (2005) 1.07
Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res (2007) 1.05
Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid (2007) 1.05
Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid (2002) 1.05
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol (2003) 1.05
Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg (2008) 1.04
VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol (2005) 1.04
Histopathology of gastrointestinal neuroendocrine neoplasms. Front Oncol (2013) 1.04
Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg (2007) 1.03
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J Infect Dis (2002) 1.03
Inflammatory pseudotumor of the thyroid gland showing prominent fibrohistiocytic proliferation. A case report. Endocr Pathol (2009) 1.02